![Alison Long](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Long
Director/Board Member at
TAYSHA GENE THERAPIES, INC.
Net worth: 746 535 $ as of 31/05/2026
Profile
Alison Long is currently an Independent Director at Taysha Gene Therapies, Inc. since 2023 and Chief Medical Officer at Flightpath Biosciences, Inc. since 2023.
Former roles include Chief Medical Officer at Anokion SA from 2022 to 2023, Chief Medical Officer at Kaleido Biosciences, Inc. from 2021 to 2022, Chief Medical Officer & Senior Vice President at Freeline Therapeutics Holdings Ltd. in 2021, and Head-Clinical R&D at Spark Therapeutics, Inc. from 2019 to 2020.
Education includes a doctorate from George Mason University and an undergraduate degree from the University of the Witwatersrand.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/06/2026 | 127,178 ( 0.05% ) | 746 535 $ | 31/05/2026 |
Alison Long active positions
| Companies | Position | Start |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director/Board Member | 01/11/2023 |
Flightpath Biosciences, Inc.
 Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Chief Tech/Sci/R&D Officer | 01/01/2023 |
Former positions of Alison Long
| Companies | Position | End |
|---|---|---|
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Chief Tech/Sci/R&D Officer | 01/01/2023 |
| KALEIDO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01/11/2021 |
| SPARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2020 |
Training of Alison Long
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
- Stock Market
- Insiders
- Alison Long
